This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionLast revisionBoth sides next revision | ||
home:mp:olmesartan:response [08.23.2017] – [Increase in immunopathology] sallieq | home:mp:olmesartan:response [06.05.2019] – [Patient response to olmesartan (Benicar)] sallieq | ||
---|---|---|---|
Line 1: | Line 1: | ||
====== Patient response to olmesartan (Benicar) | ====== Patient response to olmesartan (Benicar) | ||
+ | |||
+ | < | ||
+ | |||
Olmesartan (Benicar) has two actions. It palliates symptoms by reducing inflammation, | Olmesartan (Benicar) has two actions. It palliates symptoms by reducing inflammation, | ||
Line 35: | Line 38: | ||
- | {{tag> | + | {{tag>MP olmesartan}} |